FDA Clears HeartBeam’s Cable-Free 12-Lead ECG—A Game Changer for At-Home Heart Monitoring?
Market Chameleon (Fri, 12-Dec 9:54 AM)
FDA Clears HeartBeam’s Cable-Free 12-Lead ECG for At-Home Arrhythmia Assessment—Major Step Toward Personalized Cardiac Care
Market Chameleon (Thu, 11-Dec 10:30 AM)
HeartBeam Wins FDA Clearance for At-Home, Cable-Free 12-Lead ECG—Setting the Stage for Personalized Cardiac Care
Market Chameleon (Wed, 10-Dec 9:53 AM)
HeartBeam Charts Multi-Path Regulatory Strategy After FDA Decision—Clinical Study Remains a Key Strength
Market Chameleon (Fri, 28-Nov 9:52 AM)
